Based on these findings, we hypothesized that circulating NLRP3 inflammasome components, together with occludin, a structural marker reflecting BBB disruption, may serve as meaningful prognostic biomarkers in AIS. The gene discussed is NLRP3; the disease is androgen insensitivity syndrome.